Shares of Extendicare Inc. (TSE:EXE – Get Free Report) reached a new 52-week high on Tuesday . The stock traded as high as C$11.35 and last traded at C$11.31, with a volume of 84376 shares. The stock had previously closed at C$11.12.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Cormark upgraded Extendicare to a “moderate buy” rating in a research note on Wednesday. TD Securities upped their price target on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research note on Thursday, November 14th. Royal Bank of Canada upped their price objective on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a report on Thursday, November 28th. Finally, BMO Capital Markets set a C$11.00 price objective on Extendicare and gave the stock a “market perform” rating in a report on Thursday, January 30th. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Extendicare currently has an average rating of “Hold” and a consensus target price of C$10.25.
Read Our Latest Research Report on Extendicare
Extendicare Stock Down 0.4 %
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be issued a dividend of $0.04 per share. The ex-dividend date is Friday, February 28th. This represents a $0.48 annualized dividend and a yield of 4.16%. Extendicare’s payout ratio is presently 61.20%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- 3 Small Caps With Big Return Potential
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Stock Splits, Do They Really Impact Investors?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.